Earnings per share for the last twelve months: Accuray Inc (ARAY)

Graphic logo of Accuray Inc. (ARAY)

High patent and R&D costs create a formidable barrier for Accuray Incorporated (ARAY) competitors. The rolling annual net income per share on this GURU.Markets platform chart, where -6.04 indicates the level of this metric, confirms the resilience of the model. Software integration into clinics fosters client dependency, while independence from macroeconomic factors transforms the business into a reliable defensive asset.

ARAY (Accuray, Inc.) Net earnings per one share for the last twelve months history from 07/04/2022 to 11/13/2026

ARAY (Accuray Inc): analytical breakdowns and indicator data

- share price and expert price forecast:
Stock Quotes Accuray Incorporated|ARAY - Analyst Consensus Forecast
- company stock exchange capitalization indicators:
Market Value Accuray|ARAY - Value Adjusted for Debt and Cash
- shareholders' equity book value data:
Book Value per Share Accuray Incorporated|ARAY - Total Stockholders' Equity|Market Capitalization to Book Value Ratio accuray.com|ARAY - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Accuray Incorporated|ARAY - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Accuray Inc.|ARAY - Company Total Debt|Debt to Book Value Accuray|ARAY - Company Long-Term Debts|Company Short-Term Debt Accuray Incorporated|Quick Ratio accuray.com
- net income and valuation multiples indicators:
ARAY - Net Profit|Future Profit Accuray Incorporated|ARAY - Market Cap to Earnings|Projected Price to Earnings Accuray|ARAY - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Accuray|ARAY - Operating income before deduction of amortization|Earnings per share for the last twelve months Accuray Incorporated|ARAY - Earnings per share for the last 12 months|Quarterly EPS earnings growth accuray.com|ARAY - Net earnings per share growth this year|Net earnings per share growth forecast for next year Accuray Incorporated
Initial company analysis:Accuray Incorporated - ARAY
Manufactured products of Accuray Inc

The efficiency of implementing innovations in high-precision radiation therapy directly determines the financial stability of Accuray Incorporated. By analyzing the rolling trailing twelve-month earnings per share, an investor can see the final net income distributed across the total share issuance, which allows for an assessment of the real return on each share of capital and the determination of the business's fair market value.

Competitors of Accuray Incorporated (ARAY)

ONC: Net earnings per share for the last 12 months|HALO - Net earnings per share (EPS TTM)|Revolution Medicines, Inc. (RVMD) - Earnings per share for the last twelve months|Ascentage Pharma Group International - Earnings per share for the trailing year|CGON (CG Oncology Corp) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months UroGen Pharma Corp URGN|Net earnings per share (EPS TTM) BCAX|Net earnings per share (EPS TTM) personalis.com (PSNL)|Net earnings per share (EPS TTM) ERAS (Erasca)|DCTH - Net earnings per share for the last 12 months|YmAbs - Net earnings per share (EPS TTM)|Aura Corp (AURA) - Net earnings per share for the last 12 months|CADL (candeltx.com) - Net earnings per share for the last 12 months|SELLAS Life Sciences Group (SLS) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Actuate Therapeutics|CTOR: Earnings per share for the trailing year|Net earnings per share (EPS TTM) HURA|Net earnings per share (EPS TTM) Protara Tx (TARA)|Fate Therapeutics, Inc. - Net earnings per share for the last 12 months|Aadi Bioscience, Inc. (WHWK) - Net earnings per one share for the last twelve months|TCRX: Net earnings per share for the last 12 months|Earnings per share for the trailing year CSBR (Champions Oncology)|XBIT: Net earnings per share (EPS TTM)|CVM - Net earnings per share for the last four quarters|Earnings per share for the last twelve months OS Therapies Incorporated|Earnings per share for the last 12 months RADX (radiopharmtheranostics.com)|Net earnings per share (EPS TTM) ARTV|Net earnings per share for the last 12 months adlainortye.com ANL|Earnings per share for the last twelve months Veru Pharma VERU|Tempest Therapeutics Corp (TPST) - Net earnings per one share for the last twelve months|XLO - Earnings per share for the last twelve months|Earnings per share for the trailing year RENB (Renovaro Inc.)|muraloncology.com (MURA) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months KAPA (Kairos Pharma)|Earnings per share for the last twelve months OnKure Therapeutics, Inc.|Net earnings per one share for the last twelve months CytoMed GDTC|Earnings per share for the last twelve months Curis, Inc. (CRIS)|APLM (apollomicsinc.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) THAR (Tharimmune)|Net earnings per share (EPS TTM) Advanced Biomed Inc. ADVB|GNPX: Net earnings per share for the last 12 months|Calidi Biotherapeutics - Earnings per share for the last four quarters|SBFM: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Xenetic Biosciences, Inc. (XBIO)|SLRX (Salarius Pharmaceuticals, Inc.) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months PPBT (Purple Biotech Ltd)|Net earnings per share (EPS TTM) AONC|Net earnings per share (EPS TTM) BeiGene Ltd (BGNE)|Earnings per share for the last twelve months Checkpoint Therapeutics CKPT|Earnings per share for the trailing year ELEV|iCAD Corp - Net earnings per share (EPS TTM)|IKNA - Net earnings per share (EPS TTM)|NTBL (Notable Labs Inc.) - Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months Viracta Therapeutics, Inc. (VIRX)|MOR (MorphoSys AG) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months nayabiosciences.com (NAYA)|Net earnings per share (EPS TTM) AAPGV